Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
Saved in:
| Title: | Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial. |
|---|---|
| Authors: | Semitala FC; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala, Uganda., Kadota JL; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Nabunje J; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda., Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda., Bishop O; Infectious Diseases Research Collaboration, Kampala, Uganda., Patel D; The Better Lab, Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America., Sammann A; The Better Lab, Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America., Nahid P; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Belknap R; Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, United States of America., Kamya MR; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda., Handley MA; Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America., Phillips PPJ; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Katahoire A; Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Berger CA; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Kiwanuka N; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Katamba A; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda., Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Cattamanchi A; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda. |
| Source: | PLoS medicine [PLoS Med] 2021 Dec 16; Vol. 18 (12), pp. e1003875. Date of Electronic Publication: 2021 Dec 16 (Print Publication: 2021). |
| Publication Type: | Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Pragmatic Clinical Trial |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
